<?xml version="1.0" encoding="UTF-8"?>
<p>With respect to mutant viruses, A/HebeiXinhua/SWL1106/2017 (oseltamivir and amantadine-resistant H1N1) and mutant A/FujianXinluo/SWL2457/2014 (amantadine-resistant H1N1), quercetin, luteolin, and apigenin could more effectively reduce viral activity or impair the adsorption of viruses on the cells compared to amantadine and oseltamivir [
 <xref rid="B140-biomolecules-11-00010" ref-type="bibr">140</xref>]. This study provided an experimental foundation for the development of broad-spectrum antiviral drugs. It also provided an efficient multitarget predictive tool for the discovery of new drugs against influenza [
 <xref rid="B140-biomolecules-11-00010" ref-type="bibr">140</xref>].
</p>
